» Articles » PMID: 28100038

TRIM8 Regulates Stemness in Glioblastoma Through PIAS3-STAT3

Overview
Journal Mol Oncol
Date 2017 Jan 19
PMID 28100038
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma (GBM) is the most malignant form of primary brain tumor, and GBM stem-like cells (GSCs) contribute to the rapid growth, therapeutic resistance, and clinical recurrence of these fatal tumors. STAT3 signaling supports the maintenance and proliferation of GSCs, yet regulatory mechanisms are not completely understood. Here, we report that tri-partite motif-containing protein 8 (TRIM8) activates STAT3 signaling to maintain stemness and self-renewing capabilities of GSCs. TRIM8 (also known as 'glioblastoma-expressed ring finger protein') is expressed equally in GBM and normal brain tissues, despite its hemizygous deletion in the large majority of GBMs, and its expression is highly correlated with stem cell markers. Experimental knockdown of TRIM8 reduced GSC self-renewal and expression of SOX2, NESTIN, and p-STAT3, and promoted glial differentiation. Overexpression of TRIM8 led to higher expression of p-STAT3, c-MYC, SOX2, NESTIN, and CD133, and enhanced GSC self-renewal. We found that TRIM8 activates STAT3 by suppressing the expression of PIAS3, an inhibitor of STAT3, most likely through E3-mediated ubiquitination and proteasomal degradation. Interestingly, we also found that STAT3 activation upregulates TRIM8, providing a mechanism for normalized TRIM8 expression in the setting of hemizygous gene deletion. These data demonstrate that bidirectional TRIM8-STAT3 signaling regulates stemness in GSC.

Citing Articles

An integrative analysis based on multiple cell death patterns identifies an immunosuppressive subtype and establishes a prognostic signature in lower-grade glioma.

Lian H, Wang J, Yan S, Chen K, Jin L Ann Med. 2024; 56(1):2412831.

PMID: 39387560 PMC: 11469432. DOI: 10.1080/07853890.2024.2412831.


STAT3 Protein-Protein Interaction Analysis Finds P300 as a Regulator of STAT3 and Histone 3 Lysine 27 Acetylation in Pericytes.

Kundu G, Ghasemi M, Yim S, Rohil A, Xin C, Ren L Biomedicines. 2024; 12(9).

PMID: 39335615 PMC: 11428717. DOI: 10.3390/biomedicines12092102.


Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway.

Ma Z, Zhou F, Jin H, Wu X Cells. 2024; 13(12.

PMID: 38920657 PMC: 11201928. DOI: 10.3390/cells13121027.


TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1.

Yu C, Wang J, Li Y Biochem Genet. 2024; .

PMID: 38918306 DOI: 10.1007/s10528-024-10865-8.


PIAS family in cancer: from basic mechanisms to clinical applications.

Li X, Rasul A, Sharif F, Hassan M Front Oncol. 2024; 14:1376633.

PMID: 38590645 PMC: 10999569. DOI: 10.3389/fonc.2024.1376633.


References
1.
Park D, Rich J . Biology of glioma cancer stem cells. Mol Cells. 2009; 28(1):7-12. DOI: 10.1007/s10059-009-0111-2. View

2.
Carro M, Lim W, Alvarez M, Bollo R, Zhao X, Snyder E . The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2009; 463(7279):318-25. PMC: 4011561. DOI: 10.1038/nature08712. View

3.
Chen G, Kong J, Tucker-Burden C, Anand M, Rong Y, Rahman F . Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. Cancer Res. 2014; 74(16):4536-48. PMC: 4134737. DOI: 10.1158/0008-5472.CAN-13-3703. View

4.
Levy D, Darnell Jr J . Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002; 3(9):651-62. DOI: 10.1038/nrm909. View

5.
Dasgupta A, Raychaudhuri B, Haqqi T, Prayson R, Van Meir E, Vogelbaum M . Stat3 activation is required for the growth of U87 cell-derived tumours in mice. Eur J Cancer. 2009; 45(4):677-84. PMC: 5424891. DOI: 10.1016/j.ejca.2008.11.027. View